Deciphera Pharmaceuticals, Inc.
DCPHDelisted Jun 11, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001654151
Deciphera Pharmaceuticals, Inc. was delisted on Jun 11, 2024; its insiders filed their last Form 4 on Jun 11, 2024; 177 institutions reported holding it in 13F filings for Q1 2024, worth $943.7M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Deciphera Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 145 | 157 | +12 |
| Shares | 56.2M | 56.6M | +360.8K (+0.6%) |
| Value | $792.1M | $719.6M | −$72.5M (−9.1%) |
New holders (26)
Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (14)
Institutions that held Deciphera Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Ikarian Capital, LLC | 174,510 | $2.46M |
| Bank of Montreal | 92,060 | $1.33M |
| First Trust Advisors LP | 71,501 | $1.01M |
| Alberta Investment Management Corp | 37,791 | $532.1K |
| Trexquant Investment LP | 36,402 | $512.5K |
| Boothbay Fund Management, LLC | 30,236 | $425.7K |
| Adage Capital Partners GP, L.L.C. | 29,661 | $417.6K |
| Ergoteles LLC | 16,309 | $229.6K |
| Graham Capital Management, L.P. | 15,448 | $217.5K |
| Belvedere Trading LLC | 14,463 | $203.6K |
| Los Angeles Capital Management LLC | 13,435 | $189.2K |
| Massachusetts Financial Services Co | 13,219 | $186.1K |
| E Fund Management Co., Ltd. | 12,429 | $175.0K |
| Franklin Resources Inc | 10,942 | $154.1K |